Get the app!
Back to Trades
Total Value
$31.5K
Net $31.5K bought
Filing Date
Dec 4, 2025
2 transactions
Purchases
$31.5K
2 transactions

Trade Summary

On Dec 3, 2025 through Dec 4, 2025, te Boekhorst Paul Francis Olivier, President and CEO, Director, purchased $31.5K of IMMUCELL CORP /DE/ (ICCC) across 2 transactions. The filing covers Common Stock $0.10 par value per share and reflects net buying of $31.5K. Reported prices ranged from $5.04 to $5.50. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Company Name
IMMUCELL CORP /DE/
Ticker Symbol
ICCC
CIK
0000811641

Insider Information

Role
President and CEO, Director
Location
PORTLAND, ME

Filing Details

Filing Date
Dec 4, 2025
Transaction Date
Dec 3, 2025
Accession Number
0001437749-25-036913
Form Type
4
Net Trading Amount
$31.5K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Dec 3, 2025Common Stock $0.10 par value per share3,598$5.04Purchase$18.2K
Dec 4, 2025Common Stock $0.10 par value per share2,432$5.50Purchase$13.4K

Want live alerts when te Boekhorst Paul Francis Olivier trades again?

Download Insider Trades to track ICCC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased.
  2. (F2)This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.